NMLSF closed Friday higher at $0.01, an increase of 0% from Thursday's close, completing a monthly decrease of -79.7505% or -$0.05. Over the past 12 months, NMLSF stock lost -84.7001%.
NMLSF is not paying dividends to its shareholders.
The last earnings report, released on May 20, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0071%, based on the last three reports.
Restart Life Sciences Corp. has completed 5 stock splits, with the recent split occurring on Jan 24, 2025.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on XFRA (EUR).